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ABSTRACT: During the past decade, use of organophosphate
compounds as flame retardants and plasticizers has increased.
Numerous studies investigating biomarkers (i.e., urinary metabo-
lites) demonstrate ubiquitous human exposure and suggest that
human exposure may be increasing. To formally assess temporal
trends, we combined data from 14 U.S. epidemiologic studies for
which our laboratory group previously assessed exposure to two
commonly used organophosphate compounds, tris(1,3-dichloro-2-
propyl) phosphate (TDCIPP) and triphenyl phosphate (TPHP).
Using individual-level data and samples collected between 2002 and
2015, we assessed temporal and seasonal trends in urinary bis(1,3-
dichloro-2-propyl) phosphate (BDCIPP) and diphenyl phosphate (DPHP), the metabolites of TDCIPP and TPHP, respectively.
Data suggest that BDCIPP concentrations have increased dramatically since 2002. Samples collected in 2014 and 2015 had
BDCIPP concentrations that were more than 15 times higher than those collected in 2002 and 2003 (10β = 16.5; 95% confidence
interval from 9.64 to 28.3). Our results also demonstrate significant increases in DPHP levels; however, increases were much
smaller than for BDCIPP. Additionally, results suggest that exposure varies seasonally, with significantly higher levels of exposure
in summer for both TDCIPP and TPHP. Given these increases, more research is needed to determine whether the levels of
exposure experienced by the general population are related to adverse health outcomes.
■ INTRODUCTION
Polybrominated diphenyl ethers (PBDEs) were once among
the most widely used flame retardant chemicals applied to
consumer products; however, concern over their persistence
and toxicity led to their phase-out beginning in the early 2000s.
Since then, the chemical flame retardant industry has moved
toward replacements.1−5 One class of alternatives consists of
the organophosphate flame retardants (PFRs), which include
chlorinated alkyl phosphates [e.g., tris(1,3-dichloro-2-propyl)
phosphate (TDCIPP)] and nonhalogenated aryl phosphates
[e.g., triphenyl phosphate (TPHP)]. Data suggest that PFR use
increased after the PBDE phase-out, and they are now among
the most commonly detected flame retardants in furniture and
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electronics.1−5 Additionally, PFRs are used in other products.
For example, TPHP is used as a plasticizer and is found in a
variety of applications (e.g., nail polish6). Like PBDEs, PFRs are
additives that are not chemically bound to products.
Consequently, they migrate into indoor air and dust, where
they are ubiquitously detected.7−10
In humans, PFRs are thought to be rapidly metabolized and
excreted in urine (t1/2 of approximately hours). PFR
metabolites are used as exposure biomarkers and have been
detected in urine samples from people living around the
world.6,11−27 Although data suggest PFR exposure is wide-
spread and potentially increasing, past studies have been limited
in their ability to assess exposure trends because they have
generally been conducted over relatively short periods. In
addition, comparisons of metabolite concentrations across
studies have been limited by differences in cohort composition
and potential interlab variability.28 However, by compiling
individual-level data from 14 U.S.-based epidemiologic studies
conducted by our laboratory in 2002−2015, we are able to
more thoroughly evaluate temporal trends in urinary PFR
metabolite concentrations. Here, we assess temporal trends in
metabolites of TDCIPP and TPHP, bis(1,3-dichloro-2-propyl)
phosphate (BDCIPP) and diphenyl phosphate (DPHP),
respectively.
■ MATERIALS AND METHODS
Study Populations. Data were compiled from epidemio-
logic studies for which our laboratory group previously
measured urinary PFR metabolites [857 individuals (Table
1)].6,11,14−24,29 Descriptive studies were reported previously
and are not discussed in detail here. Briefly, urine samples were
collected in 2002−2015 and analyzed in 2009−2016. Individual
studies were primarily located in North Carolina or the
Northeastern United States, with the exception of one
California cohort. Several studies included measurements of
the same individuals at multiple time points; however, because
measurements were generally closely spaced (i.e., days to weeks
apart), we included a single measurement per participant,
selected as the first urine sample,18,19 or the last for the FLaRE
study that included only children at the final assessment.29 In
addition, two studies were designed to assess contributions of
specific exposure sources (fingernail polish and gymnastics
practice).6,22 From these studies, we selected the measurements
intended to represent background exposure. All protocols were
reviewed and approved by the relevant Institution Review
Boards.
Urine Analysis. Extraction and analysis procedures for
BDCIPP and DPHP have been described previously.11,14,15
Briefly, samples were extracted and cleaned with solid-phase
extraction (SPE) techniques (Table 1), using identical columns
and sorbent material (Strata-X-AW). Some studies included an
enzyme digestion step prior to SPE for analysis of BCIPHIPP
sulfate and glucuronide conjugates, but this is not expected to
bias DPHP and BDCIPP concentrations because they have no
known conjugated metabolites.30 In all studies, deuterium-
labeled standards of DPHP and BDCIPP were used for
quantification by spiking prior to SPE, and recoveries of
internal standards through the extraction process were
quantified using 13C-labeled DPHP. All samples were analyzed
using liquid chromatography and tandem mass spectrometry
(LC−MS/MS), although ionization techniques differed be-
tween studies, either atmospheric pressure chemical ionization
or electrospray ionization. All studies employed thorough QA/
QC programs with laboratory blanks and duplicates. Specific
gravity was also measured in samples prior to analysis using a
digital hand-held refractometer (Atago).
Covariate Data. Although included studies varied in terms
of collected covariates, all recorded the date that samples were
collected. Individual participant ages were available for 97.1% of
participants. If missing, age was imputed as a random number
within one standard deviation of the study mean. However,
eight women from ref 18 were assigned 32 years of age as they
were missing data on age but were known to be pregnant. Sex
was available for 99.5% of participants and was randomly
imputed for the four participants for which it was missing.
Pregnancy status was confirmed for many female partic-
ipants;17,18,29 however, if pregnancy status was not obtained,
we assumed they were not pregnant. While the majority of
urine samples were spot urines, 40 were first-morning voids and
eight were 24 h collections.
Statistical Analysis. Previous publications from each study
demonstrate frequent detection of BDCIPP and DPHP. If a
particular metabolite was not detected, we imputed the
concentration as the method detection limit divided by 2. We
visually assessed plots of metabolite concentrations over time
(Figure 1) and evaluated the shape of potential relationships
using smoothing. On the basis of plot and smoothing results,
which suggested that relationships between the date of
Figure 1. Urinary PFR metabolite levels by year. Individual participant values are shown for adults (green) and children (blue). Black dots indicate
the geometric mean in each cohort [two geometric means are shown for refs 20 (blue fill), 19 (yellow fill), and 6 (red fill) because samples were
collected over two sampling campaigns with different participants].
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collection and metabolite levels were nonlinear, collection times
were categorized into 2 year periods for analyses. Metabolite
concentrations were not normally distributed and were log-
transformed in regression analyses. β coefficients from these
models were exponentiated for interpretation and represent the
multiplicative change in metabolite concentration. Analyses
were adjusted for age (continuous), sex (male, nonpregnant
female, and pregnant female), and season of collection, factors
that previous research suggests may be related to PFR
metabolite concentrations.12,17,19 We also considered potential
confounding by the number of years a sample had been stored
prior to analysis; however, storage time (continuous) was
strongly collinear with collection date as older samples tended
to be stored longer than newer samples before analysis. To
address this issue, we dichotomized storage time at 1 year. The
dichotomized storage time was not associated with urinary
metabolite concentrations and was excluded from the final
adjustment set. Although we do not expect the enzyme
digestion step or the differing ionization techniques to impact
BDCIPP and DPHP levels, we considered potential confound-
ing by the analysis method. The method was not associated
with urinary metabolite concentrations and was dropped from
analyses. Because previous results suggest that children have
greater exposure to PFRs than adults do,12,14−16,25 and children
were concentrated in later years of sample collection, we
conducted analyses separately for children (≤10 years of age)
and adults (≥18 years of age). To account for urine dilution, we
present results using specific gravity-corrected urine concen-
trations;31 however, uncorrected analyses produced nearly
identical results (not shown). Statistical analyses were
conducted in SAS version 9.4.
We conducted sensitivity analyses to determine the robust-
ness of results to assumptions about cohort composition,
sample type, and analysis. To evaluate the impact of including
participants with missing data, we conducted analyses restricted
to participants with complete data. In addition, we conducted
analyses including only spot urine samples. Results were
indistinguishable from those using all data. Additionally, our
final data set contained a number of pregnant women,
particularly the 2002−2005 set. To ensure that temporal
patterns were not driven by time-dependent differences in the
types of participants included (e.g., pregnant women), we
conducted secondary analyses excluding pregnant women.
Finally, data were collected in several different geographic
regions, including California, where exposure may be higher
because of stronger flammability standards. We additionally
conducted analyses excluding California participants.
■ RESULTS AND DISCUSSION
Thirteen studies included adults who ranged in age from 18 to
67 years [n = 741; mean age of 32.3 ± 9.3 years (Table 1)].
Three of these studies included children, and one additional
study focused exclusively on children [n = 116; mean age of 2.8
± 2.2 years (Table 1)]. Among adults, 73.7% of participants
were female, and of those, 65.5% were pregnant. Children were
more evenly distributed by sex than adults (53.4% male).
BDCIPP and DPHP were detectable in >83% of samples
from each study and were detected overall in 96 and 91% of
samples, respectively. Individual study participants’ metabolite
concentrations are shown in Figure 1 along with geometric
mean metabolite concentrations for each study. As reported
previously, samples from children tended to have metabolite
concentrations higher than the concentrations of those from
adults, particularly for BDCIPP, a finding highlighted in many
studies.12,14−16,25 BDCIPP and DPHP levels also tended to be
higher among pregnant women, suggesting differences in
metabolism and excretion or exposure behavior patterns during
pregnancy.
Our results suggest that urinary BDCIPP levels have
increased dramatically in recent years (Table 2). Among adults,
Table 2. Regression Analyses with Year (two-year categories) and Season (four categories) of Sample Collection as a Predictor
of Urinary PFR Metabolite Levelsa
BDCIPP DPHP
no. 10β (95% CI) p value 10β (95% CI) p value
adults (≥18 years of age)
2002−2003 132 reference − reference −
2004−2005 248 1.22 (0.98, 1.52) 0.08 1.02 (0.83, 1.26) 0.83
2006−2007 1 − − − −
2008−2009 40 0.81 (0.50, 1.31) 0.39 1.56 (0.99, 2.47) 0.06
2010−2011 67 2.41 (1.57, 3.70) <0.0001 2.98 (1.99, 4.46) <0.0001
2012−2013 157 6.86 (4.66, 10.1) <0.0001 2.94 (2.04, 4.23) <0.0001
2014−2015 96 16.5 (9.64, 28.3) <0.0001 1.93 (1.16, 3.20) 0.01
winter 206 reference − reference −
spring 185 2.06 (1.67, 2.53) <0.0001 0.99 (0.81, 1.20) 0.90
summer 238 4.13 (3.39, 5.04) <0.0001 1.54 (1.27, 1.85) <0.0001
fall 112 1.77 (1.38, 2.26) <0.0001 0.97 (0.77, 1.23) 0.82
children (≤10 years of age)
2010−2011 14 reference − reference −
2012−2013 25 1.02 (0.28, 3.69) 0.98 0.65 (0.26, 1.60) 0.34
2014−2015 77 3.90 (1.36, 11.1) 0.01 0.74 (0.35, 1.54) 0.41
winter 23 reference − reference −
spring 39 2.28 (0.88, 5.91) 0.09 1.70 (0.87, 3.34) 0.12
summer 32 8.48 (3.16, 22.8) <0.0001 2.34 (1.16, 4.69) 0.02
fall 22 3.03 (1.32, 6.96) 0.009 0.72 (0.40, 1.29) 0.27
aExponentiated β coefficients represent the multiplicative change in metabolite concentrations relative to the reference group. Analyses stratified by
age and adjusted for sex (male, nonpregnant female, and pregnant female), age (continuous), year of collection, and season of collection.
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samples collected in 2014 and 2015 had BDCIPP concen-
trations that were 16.5 times those in urine samples collected in
2002 and 2003 [95% confidence interval (CI) from 9.64 to 28.3
(Table 2)]. Although the range of collection dates was
narrower, samples from children displayed similar trends;
children providing samples in 2014 and 2015 had urinary
BDCIPP concentrations that were 3.90 times those in samples
collected in 2010 and 2011 [95% CI from 1.36 to 11.1 (Table
2)]. Time trends were similar and slightly stronger when we
excluded pregnant women (Table S1). When we excluded
California participants, patterns of association remained very
similar (Table S2).
Previous research demonstrates that TDCIPP is commonly
used in residential furniture and is widely detected in indoor
environments; however, there have been few evaluations of
temporal trends in different matrices.3,8 In a small California
house dust assessment, TDCIPP levels were stable between
2006 and 2011.9 Interestingly, we saw the largest increases in
urinary BDCIPP after this period. Additional data investigating
the presence of TDCIPP in residential furniture suggest that
use may have increased after the Penta-BDE phase-out but has
declined since 2014.3 It will take several more years of data
collection to determine if these decreases will impact exposure.
Urinary DPHP concentrations were significantly higher for
samples collected in 2010−2015 compared to samples collected
in 2002 and 2003. For example, samples collected in 2010 and
2011 had urinary DPHP concentrations 2.98 times those of
samples collected in 2002 and 2003 [95% CI from 1.99 to 4.46
(Table 2)]. Although concentrations were also significantly
higher in 2014 and 2015, the magnitude of the effect (i.e., OR =
1.93) was smaller than the effect estimates for 2010 and 2011
or 2012 and 2013, suggesting exposure may have peaked during
this period and could be in decline. We observed no trends in
DPHP concentrations among children; however, children’s
samples were collected over a period narrower than that of
adults (Table 2). Excluding pregnant women and California
participants had little impact on results (Tables S1 and S2).
Our results showing increases in DPHP are consistent with a
small study showing TPHP increases in household dust
between 2006 and 2011.9 Although long-term human exposure
trends have not been assessed previously, to the best of our
knowledge, short-term trends were recently evaluated in pooled
samples from Chinese adults.32 Ma et al. reported no change in
TPHP concentrations between samples collected in 2011 and
2015 in China, suggesting that exposure levels were relatively
constant during this period.32 Our results suggest that TPHP
exposure may have started to decrease post-2011, suggesting
that TPHP use as a flame retardant or in other applications
could be decreasing. Although urinary DPHP is thought to be
an indicator of TPHP exposure, other compounds may be
metabolized to DPHP and DPHP itself may be used in
consumer products.33
A seasonal trend was observed in urinary BDCIPP;
concentrations were significantly higher in spring, summer,
and fall than in winter. For example, BDCIPP concentrations
were 4.13 times as high in summer as in winter [95% CI from
3.39 to 5.04 (Table 2)]. DPHP concentrations were also higher
in summer but to a lesser degree [10β = 1.54; 95% CI from 1.27
to 1.85 (Table 2)] and were not statistically different in spring
and fall versus winter. Cumulatively, these findings suggest that
PFR exposure could be temperature-dependent. Indoor
temperatures are generally more stable, suggesting that outdoor
air or other microenvironments could be more important
drivers of exposure than previously thought. TDCIPP is
commonly used in automobiles,34 so it is possible that
temperature fluctuations in automobiles (e.g., from sitting in
the sun) are driving seasonal exposure differences. Alternatively,
seasonal behavior changes could explain patterns (e.g.,
differences in time spent indoors or changes in ventilation).
Regardless of the underlying reason, our results suggest the
season of collection could be an important factor to consider in
epidemiologic studies relying on single urine samples to assess
long-term exposure.
Our results represent the first long-term assessment of
human PFR exposure and have the advantage of including
numerous measurements conducted by the same laboratory.
However, our results should be interpreted in the context of
several important limitations. First, data were collected for
research of various, unrelated hypotheses; therefore, the study
populations included are not representative of the general
population. A randomly selected population with longitudinal
follow-up would provide a stronger resource for evaluating
trends. Several other groups have measured urinary PFR
metabolites in different parts of the world.12,13,25−27 With the
exception of samples from Australia, which had substantially
higher DPHP levels,12 observed concentrations were similar or
slightly lower than those analyzed by our group in U.S. studies
for the time period under evaluation. We analyzed samples at
different points in time with variable storage times and
conditions. We did not find associations between concentration
and storage times greater than or less than 1 year; however, we
were unable to evaluate differences with finer granularity
because of collinearity between storage time and collection
date. It is possible that samples could degrade over time and
potentially impact concentrations; however, this seems unlikely
to explain the patterns we observed because we do not see
patterns of decrease in analyses with SRM 3673, which we have
analyzed numerous times, with variable storage durations.
Storage containers were also different across studies; however,
it is unlikely that storage method (i.e., glass or plastic)
influenced our results, as recent work by Carignan et al.
indicates little impact on metabolite concentration.35 Addition-
ally, our analyses primarily relied on spot urine samples. While
previous research suggests that spot urine samples are reliable
estimates of exposure over time, they are likely subject to
greater variation in individual PFR concentrations than first-
morning voids or 24 h urine collections because of the rapid
metabolism of PFRs.18,19 This may explain some of the
variability in metabolite concentrations observed. Using
individual average urine concentrations rather than spot urine
measures would reduce observed scatter in the data. However,
we feel that it is unlikely that our use of spot urine samples in
this analysis is driving the observed trends. Finally, it is possible
that residual confounding may influence the observed differ-
ences (e.g., body mass index and behavioral characteristics) but
would have to be very strong to explain the entirety of observed
trends.
TDCIPP exposure, as indicated by urinary BDCIPP levels,
appears to have increased over the past 15 years. Similarly, our
data suggest that TPHP exposure also may have increased 2002
to 2011 but may have leveled off or decreased since 2011.
Additional data are urgently needed to determine whether
levels of exposure experienced by the general population are
related to adverse health outcomes.
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